Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Nanoethosomes can improve the skin penetration of Lidocaine for topical use.

The ARTAS robotic system for hair restoration is efficient with fewer cuts than manual methods, but it's limited to certain hair types and can still leave scars.

The girl with autoimmune hair loss might regrow hair within a year, and treatments can help but not prevent recurrence; dermatologist referral and corticosteroids are recommended.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Melasma treatment is difficult, but combination therapies and personalized plans show promise.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Plant cell culture is a promising method for creating sustainable and high-quality cosmetic ingredients.

Skin reactions from cancer treatments might predict how well the treatments work.

Nanoparticles effectively deliver water-insoluble drugs to hair follicles, stimulating hair growth without irritating the skin.

Nanovesicles improve drug delivery through the skin, offering better treatment outcomes and fewer side effects.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Transethosomes improve drug delivery through the skin and show promise for treating various conditions.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

The review emphasizes the need to recognize skin conditions that affect hair follicles and sweat glands to avoid misdiagnosis.

Best solution for storing hair grafts is saline with ATP at 4 degrees Celsius, but no definitive best method was confirmed.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Acne is common in women, often hormone-related, negatively affects quality of life, and requires various treatments.

Using longer PEG chains helps nanoparticles penetrate hair follicles better, improving drug delivery for conditions like alopecia.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.